This inventor holds 34 USPTO granted patents and 35 published patent applications and 14 EPO patents, primarily in Cancer Therapeutics. Top assignees: Revolution Medicines, Inc., Exelixis, Inc., Sfunga Therapeutics, Inc.. Active years: 2010-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Redwood City, CA (US) (2020 - 2023)
- Foster City, CA (US) (2010 - 2024)
Company Filing History:
21 out of 40 
10 out of 177 
3 out of 3 
Years Active: 2010-2026
Areas of Expertise:
Title: **Elena S Koltun: A Leader in Cancer Research and Pharmaceutical Innovations**
Introduction
Elena S Koltun is a prominent inventor based in Foster City, CA, known for her significant contributions to the field of cancer research. With a remarkable portfolio of 26 patents to her name, she has focused primarily on the development of innovative treatments targeting Ras proteins, which play a critical role in the progression of various cancers.
Latest Patents
Among her latest patents, Elena has made substantial advancements in the area of Ras inhibitors. Her inventions include macrocyclic compounds and pharmaceutical compositions that effectively inhibit Ras proteins. These innovations hold promise for impactful applications in cancer treatment, showcasing her dedication to improving patient outcomes through scientific research.
Career Highlights
Elena has held key positions at notable companies in the pharmaceutical industry, including Revolution Medicines, Inc. and Exelixis, Inc. Her work in these organizations has been pivotal in the development of cutting-edge therapies aimed at treating cancer. The depth of her expertise and commitment to innovation has established her as a leader in her field.
Collaborations
Throughout her career, Elena has collaborated with esteemed colleagues, including Naing N Aay and Adrian L Gill. These partnerships have enriched her research efforts, fostering an environment of knowledge exchange and collaboration that is essential for driving innovation in cancer therapeutics.
Conclusion
Elena S Koltun’s contributions to the field of cancer research through her patents and collaborative work underscore her significant impact on pharmaceutical innovations. Her dedication to developing effective treatments for cancer continues to inspire not only her peers but also future generations of inventors and researchers in the biomedical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile